/SLXNW

SLXNW Stock - Silexion Therapeutics Ltd.

Q: What is the analyst price target for SLXNW?

Analyst price target information is not currently available for SLXNW.

Q: What is SLXNW's market cap?

Market capitalization information is not currently available for SLXNW.

Healthcare|Biotechnology|NASDAQ

$0.03+37.94%

+$0.01 (+37.94%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.04

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SLXNW

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.06

52W High$0.03

52W Low$0.03

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	$-25,000	N/A	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-12,571,000	$-4,681,000	$-1,232,342	$-943,933	$-195,860
Net Income	$-16,443,000	$-4,942,000	$584,025	$-755,218	$-195,860
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$25.49	$0.39	$0.35	$-0.46	$-0.12

Company Overview

Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.

Visit Website

Earnings History & Surprises

SLXNW

Beat Rate

67%

Last 3 quarters

Avg Surprise

+23.5%

EPS vs Estimate

Beats / Misses

2/1

Last 12 quarters

Latest EPS

$-2.88

Q4 2025

EPS Surprise History

Q2 25

+92.2%

$-0.26vs$-3.30

Q3 25

-37.1%

$-4.32vs$-3.15

Q4 25

+15.3%

$-2.88vs$-3.40

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2025	Nov 12, 2025	$-3.40	$-2.88	+15.3%	✓ BEAT
Q3 2025	Aug 12, 2025	$-3.15	$-4.32	-37.1%	✗ MISS
Q2 2025	May 13, 2025	$-3.30	$-0.26	+92.2%	✓ BEAT

Frequently Asked Questions about SLXNW

What is SLXNW's current stock price?

Silexion Therapeutics Ltd. (SLXNW) is currently trading at $0.03 per share. The stock has moved +37.94% today.

What is the analyst price target for SLXNW?

No analyst price targets are currently available for this stock.

What sector is Silexion Therapeutics Ltd. in?

Silexion Therapeutics Ltd. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.

What is SLXNW's market cap?

Silexion Therapeutics Ltd. has a market capitalization of $0.00 billion, making it a small-cap company.

Does SLXNW pay dividends?

No, Silexion Therapeutics Ltd. does not currently pay a dividend to shareholders.